RT @medicinesforEU: "The revision of the #EUPharmaLegislation will aim at boosting the potential of #GenericMedicines and #BiosimilarMedicines.
To ensure medicines availability for patients & reduce pharmaceutical expenditure, we need to invest more in this sector."
VP @MargSchinas at #MedsforEU22

🐦🔗: https://nitter.eu/ComissioEuropea/status/1542449955641720833